<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:g="http://xbrl.dcca.dk/sob" xmlns:b="http://xbrl.dcca.dk/entryBalanceSheetAccountFormIncomeStatementByNature" xmlns:h="http://xbrl.dcca.dk/mrv" xmlns:f="http://xbrl.dcca.dk/arr" xmlns:d="http://xbrl.dcca.dk/cmn" xmlns:e="http://xbrl.dcca.dk/fsa" xmlns:c="http://xbrl.dcca.dk/gsd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://xbrl.dcca.dk/entryBalanceSheetAccountFormIncomeStatementByNature http://archprod.service.eogs.dk/taxonomy/20201001/entryDanishGAAPBalanceSheetAccountFormIncomeStatementByNatureIncludingManagementsReviewStatisticsAndTax20201001.xsd"><link:schemaRef xlink:type="simple" xlink:href="http://archprod.service.eogs.dk/taxonomy/20201001/entryDanishGAAPBalanceSheetAccountFormIncomeStatementByNatureIncludingManagementsReviewStatisticsAndTax20201001.xsd"/><c:InformationOnTypeOfSubmittedReport contextRef="c1">Årsrapport</c:InformationOnTypeOfSubmittedReport><c:IdentificationNumberCvrOfSubmittingEnterprise contextRef="c1">34209936</c:IdentificationNumberCvrOfSubmittingEnterprise><c:NameOfSubmittingEnterprise contextRef="c1">Grant Thornton, Statsautoriseret Revisionspartnerselskab</c:NameOfSubmittingEnterprise><c:AddressOfSubmittingEnterpriseStreetAndNumber contextRef="c1">Stockholmsgade, 45</c:AddressOfSubmittingEnterpriseStreetAndNumber><c:AddressOfSubmittingEnterprisePostcodeAndTown contextRef="c1">2100, København Ø</c:AddressOfSubmittingEnterprisePostcodeAndTown><c:PrecedingReportingPeriodStartDate contextRef="c1">2020-01-01</c:PrecedingReportingPeriodStartDate><c:PredingReportingPeriodEndDate contextRef="c1">2020-12-31</c:PredingReportingPeriodEndDate><c:ReportingPeriodStartDate contextRef="c1">2021-01-01</c:ReportingPeriodStartDate><c:ReportingPeriodEndDate contextRef="c1">2021-12-31</c:ReportingPeriodEndDate><c:IdentificationNumberCvrOfReportingEntity contextRef="c1">35861637</c:IdentificationNumberCvrOfReportingEntity><c:NameOfReportingEntity contextRef="c1">Greatop Science &amp; Technology Development (Denmark) ApS</c:NameOfReportingEntity><c:AddressOfReportingEntityStreetName contextRef="c1">Østerøvej</c:AddressOfReportingEntityStreetName><c:AddressOfReportingEntityStreetBuildingIdentifier contextRef="c1">113</c:AddressOfReportingEntityStreetBuildingIdentifier><c:AddressOfReportingEntityPostCodeIdentifier contextRef="c1">5800</c:AddressOfReportingEntityPostCodeIdentifier><c:AddressOfReportingEntityDistrictName contextRef="c1">Nyborg</c:AddressOfReportingEntityDistrictName><d:NameOfAuditFirm contextRef="c37">Grant Thornton, Statsautoriseret Revisionspartnerselskab</d:NameOfAuditFirm><d:NameOfAuditFirm contextRef="c38">Grant Thornton, Statsautoriseret Revisionspartnerselskab</d:NameOfAuditFirm><d:IdentificationNumberCvrOfAuditFirm contextRef="c37">34209936</d:IdentificationNumberCvrOfAuditFirm><d:IdentificationNumberCvrOfAuditFirm contextRef="c38">34209936</d:IdentificationNumberCvrOfAuditFirm><d:NameAndSurnameOfAuditor contextRef="c37">Jan Tønnesen</d:NameAndSurnameOfAuditor><d:NameAndSurnameOfAuditor contextRef="c38">Nikolai Selch</d:NameAndSurnameOfAuditor><d:DescriptionOfAuditor contextRef="c37">statsautoriseret revisor</d:DescriptionOfAuditor><d:DescriptionOfAuditor contextRef="c38">statsautoriseret revisor</d:DescriptionOfAuditor><d:IdentificationNumberOfAuditor contextRef="c37">mne9459</d:IdentificationNumberOfAuditor><d:IdentificationNumberOfAuditor contextRef="c38">mne42812</d:IdentificationNumberOfAuditor><c:AddressOfAuditorStreetName contextRef="c37">Stockholmsgade</c:AddressOfAuditorStreetName><c:AddressOfAuditorStreetName contextRef="c38">Stockholmsgade</c:AddressOfAuditorStreetName><c:AddressOfAuditorStreetBuildingIdentifier contextRef="c37">45</c:AddressOfAuditorStreetBuildingIdentifier><c:AddressOfAuditorStreetBuildingIdentifier contextRef="c38">45</c:AddressOfAuditorStreetBuildingIdentifier><c:AddressOfAuditorPostCodeIdentifier contextRef="c37">2100</c:AddressOfAuditorPostCodeIdentifier><c:AddressOfAuditorPostCodeIdentifier contextRef="c38">2100</c:AddressOfAuditorPostCodeIdentifier><c:AddressOfAuditorDistrictName contextRef="c37">København Ø</c:AddressOfAuditorDistrictName><c:AddressOfAuditorDistrictName contextRef="c38">København Ø</c:AddressOfAuditorDistrictName><c:AddressOfAuditorCountry contextRef="c37">Danmark</c:AddressOfAuditorCountry><c:AddressOfAuditorCountry contextRef="c38">Danmark</c:AddressOfAuditorCountry><c:TelephoneNumberOfAuditor contextRef="c37">+45 33 110 220</c:TelephoneNumberOfAuditor><c:TelephoneNumberOfAuditor contextRef="c38">+45 33 110 220</c:TelephoneNumberOfAuditor><c:EmailOfAuditor contextRef="c1">info@dk.gt.com</c:EmailOfAuditor><c:EmailOfAuditor contextRef="c38">info@dk.gt.com</c:EmailOfAuditor><c:DateOfGeneralMeeting contextRef="c1">2022-06-14</c:DateOfGeneralMeeting><c:NameAndSurnameOfChairmanOfGeneralMeeting contextRef="c1">Tongzhou Wang</c:NameAndSurnameOfChairmanOfGeneralMeeting><e:ClassOfReportingEntity contextRef="c1">Regnskabsklasse B</e:ClassOfReportingEntity><d:TypeOfAuditorAssistance contextRef="c1">Andre erklæringer uden sikkerhed</d:TypeOfAuditorAssistance><c:ToolForPreparingTheXBRLInstanceDocument contextRef="c1">Revisorgruppen Danmark</c:ToolForPreparingTheXBRLInstanceDocument><f:AddresseeOfAuditorsReportOnOtherReport contextRef="c1">anpartshaverne</f:AddresseeOfAuditorsReportOnOtherReport><f:SignatureOfAuditorsPlace contextRef="c1">København</f:SignatureOfAuditorsPlace><f:SignatureOfAuditorsDate contextRef="c1">2022-06-14</f:SignatureOfAuditorsDate><g:PlaceOfSignatureOfStatement contextRef="c1">Nyborg</g:PlaceOfSignatureOfStatement><g:DateOfApprovalOfAnnualReport contextRef="c1">2022-06-14</g:DateOfApprovalOfAnnualReport><e:GrossProfitLoss contextRef="c1" unitRef="u5" decimals="0">92093</e:GrossProfitLoss><e:GrossProfitLoss contextRef="c2" unitRef="u5" decimals="0">945009</e:GrossProfitLoss><e:EmployeeBenefitsExpense contextRef="c1" unitRef="u5" decimals="0">1074504</e:EmployeeBenefitsExpense><e:EmployeeBenefitsExpense contextRef="c2" unitRef="u5" decimals="0">1165491</e:EmployeeBenefitsExpense><e:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss contextRef="c1" unitRef="u5" decimals="0">189598</e:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss><e:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss contextRef="c2" unitRef="u5" decimals="0">219058</e:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss><e:ProfitLossFromOrdinaryOperatingActivities contextRef="c1" unitRef="u5" decimals="0">-1172009</e:ProfitLossFromOrdinaryOperatingActivities><e:ProfitLossFromOrdinaryOperatingActivities contextRef="c2" unitRef="u5" decimals="0">-439540</e:ProfitLossFromOrdinaryOperatingActivities><e:IncomeFromInvestmentsInParticipatingInterests contextRef="c1" unitRef="u5" decimals="0">-1139718</e:IncomeFromInvestmentsInParticipatingInterests><e:IncomeFromInvestmentsInParticipatingInterests contextRef="c2" unitRef="u5" decimals="0">-2215842</e:IncomeFromInvestmentsInParticipatingInterests><e:OtherFinanceIncome contextRef="c1" unitRef="u5" decimals="0">0</e:OtherFinanceIncome><e:OtherFinanceIncome contextRef="c2" unitRef="u5" decimals="0">15725</e:OtherFinanceIncome><e:OtherFinanceExpenses contextRef="c1" unitRef="u5" decimals="0">141506</e:OtherFinanceExpenses><e:OtherFinanceExpenses contextRef="c2" unitRef="u5" decimals="0">292186</e:OtherFinanceExpenses><e:ProfitLossFromOrdinaryActivitiesBeforeTax contextRef="c1" unitRef="u5" decimals="0">-2453233</e:ProfitLossFromOrdinaryActivitiesBeforeTax><e:ProfitLossFromOrdinaryActivitiesBeforeTax contextRef="c2" unitRef="u5" decimals="0">-2931843</e:ProfitLossFromOrdinaryActivitiesBeforeTax><e:TaxExpenseOnOrdinaryActivities contextRef="c1" unitRef="u5" decimals="0">1466</e:TaxExpenseOnOrdinaryActivities><e:TaxExpenseOnOrdinaryActivities contextRef="c2" unitRef="u5" decimals="0">-162767</e:TaxExpenseOnOrdinaryActivities><e:ProfitLoss contextRef="c1" unitRef="u5" decimals="0">-2454699</e:ProfitLoss><e:ProfitLoss contextRef="c2" unitRef="u5" decimals="0">-2769076</e:ProfitLoss><e:ProfitLoss contextRef="c63" unitRef="u5" decimals="0">-2454699</e:ProfitLoss><e:ProfitLoss contextRef="c64" unitRef="u5" decimals="0">-2769076</e:ProfitLoss><e:LandAndBuildings contextRef="c4" unitRef="u5" decimals="0">6842389</e:LandAndBuildings><e:LandAndBuildings contextRef="c3" unitRef="u5" decimals="0">7031987</e:LandAndBuildings><e:PropertyPlantAndEquipment contextRef="c4" unitRef="u5" decimals="0">6842389</e:PropertyPlantAndEquipment><e:PropertyPlantAndEquipment contextRef="c3" unitRef="u5" decimals="0">7031987</e:PropertyPlantAndEquipment><e:NoncurrentAssets contextRef="c4" unitRef="u5" decimals="0">6842389</e:NoncurrentAssets><e:NoncurrentAssets contextRef="c3" unitRef="u5" decimals="0">7031987</e:NoncurrentAssets><e:ShorttermTaxReceivables contextRef="c4" unitRef="u5" decimals="0">0</e:ShorttermTaxReceivables><e:ShorttermTaxReceivables contextRef="c3" unitRef="u5" decimals="0">162767</e:ShorttermTaxReceivables><e:OtherShorttermReceivables contextRef="c4" unitRef="u5" decimals="0">84037</e:OtherShorttermReceivables><e:OtherShorttermReceivables contextRef="c3" unitRef="u5" decimals="0">295269</e:OtherShorttermReceivables><e:ShorttermReceivables contextRef="c4" unitRef="u5" decimals="0">84037</e:ShorttermReceivables><e:ShorttermReceivables contextRef="c3" unitRef="u5" decimals="0">458036</e:ShorttermReceivables><e:CashAndCashEquivalents contextRef="c4" unitRef="u5" decimals="0">52255</e:CashAndCashEquivalents><e:CashAndCashEquivalents contextRef="c3" unitRef="u5" decimals="0">354065</e:CashAndCashEquivalents><e:CurrentAssets contextRef="c4" unitRef="u5" decimals="0">136292</e:CurrentAssets><e:CurrentAssets contextRef="c3" unitRef="u5" decimals="0">812101</e:CurrentAssets><e:Assets contextRef="c4" unitRef="u5" decimals="0">6978681</e:Assets><e:Assets contextRef="c3" unitRef="u5" decimals="0">7844088</e:Assets><e:RecognisedButNotOwnedAssets contextRef="c1" unitRef="u5" decimals="0">0</e:RecognisedButNotOwnedAssets><e:ContributedCapital contextRef="c4" unitRef="u5" decimals="0">1050000</e:ContributedCapital><e:ContributedCapital contextRef="c3" unitRef="u5" decimals="0">50000</e:ContributedCapital><e:RetainedEarnings contextRef="c4" unitRef="u5" decimals="0">1316822</e:RetainedEarnings><e:RetainedEarnings contextRef="c3" unitRef="u5" decimals="0">-20700679</e:RetainedEarnings><e:Equity contextRef="c4" unitRef="u5" decimals="0">2366822</e:Equity><e:Equity contextRef="c3" unitRef="u5" decimals="0">-20650679</e:Equity><e:ProvisionsForInvestmentsInParticipatingInterests contextRef="c4" unitRef="u5" decimals="0">2148858</e:ProvisionsForInvestmentsInParticipatingInterests><e:ProvisionsForInvestmentsInParticipatingInterests contextRef="c3" unitRef="u5" decimals="0">1009140</e:ProvisionsForInvestmentsInParticipatingInterests><e:Provisions contextRef="c4" unitRef="u5" decimals="0">2148858</e:Provisions><e:Provisions contextRef="c3" unitRef="u5" decimals="0">1009140</e:Provisions><e:LongtermPayablesToGroupEnterprises contextRef="c4" unitRef="u5" decimals="0">600000</e:LongtermPayablesToGroupEnterprises><e:LongtermPayablesToGroupEnterprises contextRef="c3" unitRef="u5" decimals="0">0</e:LongtermPayablesToGroupEnterprises><e:OtherLongtermPayables contextRef="c4" unitRef="u5" decimals="0">114691</e:OtherLongtermPayables><e:OtherLongtermPayables contextRef="c3" unitRef="u5" decimals="0">26818796</e:OtherLongtermPayables><e:LongtermLiabilitiesOtherThanProvisions contextRef="c4" unitRef="u5" decimals="0">714691</e:LongtermLiabilitiesOtherThanProvisions><e:LongtermLiabilitiesOtherThanProvisions contextRef="c3" unitRef="u5" decimals="0">26818796</e:LongtermLiabilitiesOtherThanProvisions><e:ShorttermPayablesToGroupEnterprises contextRef="c4" unitRef="u5" decimals="0">1145907</e:ShorttermPayablesToGroupEnterprises><e:ShorttermPayablesToGroupEnterprises contextRef="c3" unitRef="u5" decimals="0">0</e:ShorttermPayablesToGroupEnterprises><e:OtherShorttermPayables contextRef="c4" unitRef="u5" decimals="0">602403</e:OtherShorttermPayables><e:OtherShorttermPayables contextRef="c3" unitRef="u5" decimals="0">666831</e:OtherShorttermPayables><e:ShorttermLiabilitiesOtherThanProvisions contextRef="c4" unitRef="u5" decimals="0">1748310</e:ShorttermLiabilitiesOtherThanProvisions><e:ShorttermLiabilitiesOtherThanProvisions contextRef="c3" unitRef="u5" decimals="0">666831</e:ShorttermLiabilitiesOtherThanProvisions><e:LiabilitiesOtherThanProvisions contextRef="c4" unitRef="u5" decimals="0">2463001</e:LiabilitiesOtherThanProvisions><e:LiabilitiesOtherThanProvisions contextRef="c3" unitRef="u5" decimals="0">27485627</e:LiabilitiesOtherThanProvisions><e:LiabilitiesAndEquity contextRef="c4" unitRef="u5" decimals="0">6978681</e:LiabilitiesAndEquity><e:LiabilitiesAndEquity contextRef="c3" unitRef="u5" decimals="0">7844088</e:LiabilitiesAndEquity><e:WagesAndSalaries contextRef="c1" unitRef="u5" decimals="0">971184</e:WagesAndSalaries><e:WagesAndSalaries contextRef="c2" unitRef="u5" decimals="0">1062171</e:WagesAndSalaries><e:PostemploymentBenefitExpense contextRef="c1" unitRef="u5" decimals="0">103320</e:PostemploymentBenefitExpense><e:PostemploymentBenefitExpense contextRef="c2" unitRef="u5" decimals="0">103320</e:PostemploymentBenefitExpense><e:EmployeeBenefitsExpense contextRef="c1" unitRef="u5" decimals="0">1074504</e:EmployeeBenefitsExpense><e:EmployeeBenefitsExpense contextRef="c2" unitRef="u5" decimals="0">1165491</e:EmployeeBenefitsExpense><e:AverageNumberOfEmployees contextRef="c1" unitRef="u7" decimals="INF">2</e:AverageNumberOfEmployees><e:AverageNumberOfEmployees contextRef="c2" unitRef="u7" decimals="INF">2</e:AverageNumberOfEmployees><e:Equity contextRef="c119" unitRef="u5" decimals="0">50000</e:Equity><e:Equity contextRef="c478" unitRef="u5" decimals="0">50000</e:Equity><e:IncreaseOfCapital contextRef="c120" unitRef="u5" decimals="0">1000000</e:IncreaseOfCapital><e:IncreaseOfCapital contextRef="c479" unitRef="u5" decimals="0">0</e:IncreaseOfCapital><e:Equity contextRef="c121" unitRef="u5" decimals="0">1050000</e:Equity><e:Equity contextRef="c480" unitRef="u5" decimals="0">50000</e:Equity><e:Equity contextRef="c137" unitRef="u5" decimals="0">-20700679</e:Equity><e:Equity contextRef="c498" unitRef="u5" decimals="0">-17931603</e:Equity><e:ProfitLoss contextRef="c138" unitRef="u5" decimals="0">-2454699</e:ProfitLoss><e:ProfitLoss contextRef="c499" unitRef="u5" decimals="0">-2769076</e:ProfitLoss><e:TransferredFromSharePremium contextRef="c138" unitRef="u5" decimals="0">24472200</e:TransferredFromSharePremium><e:TransferredFromSharePremium contextRef="c499" unitRef="u5" decimals="0">0</e:TransferredFromSharePremium><e:Equity contextRef="c139" unitRef="u5" decimals="0">1316822</e:Equity><e:Equity contextRef="c500" unitRef="u5" decimals="0">-20700679</e:Equity><g:IdentificationOfApprovedAnnualReport contextRef="c1" xml:lang="da">Direktionen har dags dato aflagt årsrapporten for regnskabsåret 1. januar - 31. december 2021 for Greatop Science &amp; Technology Development (Denmark) ApS.
</g:IdentificationOfApprovedAnnualReport><g:IdentificationOfApprovedAnnualReport contextRef="c1" xml:lang="en">Today, the executive board has presented the annual report of Greatop Science &amp; Technology Development (Denmark) ApS for the financial year 1 January - 31 December 2021.
</g:IdentificationOfApprovedAnnualReport><g:ConfirmationThatAnnualReportIsPresentedInAccordanceWithRequirementsProvidedForByLegislationAnyStandardsAndRequirementsProvidedByArticlesOfAssociationOrByAgreement contextRef="c1" xml:lang="da">Årsrapporten er aflagt i overensstemmelse med årsregnskabsloven.
</g:ConfirmationThatAnnualReportIsPresentedInAccordanceWithRequirementsProvidedForByLegislationAnyStandardsAndRequirementsProvidedByArticlesOfAssociationOrByAgreement><g:ConfirmationThatAnnualReportIsPresentedInAccordanceWithRequirementsProvidedForByLegislationAnyStandardsAndRequirementsProvidedByArticlesOfAssociationOrByAgreement contextRef="c1" xml:lang="en">The annual report has been presented in accordance with the Danish Financial Statements Act.
</g:ConfirmationThatAnnualReportIsPresentedInAccordanceWithRequirementsProvidedForByLegislationAnyStandardsAndRequirementsProvidedByArticlesOfAssociationOrByAgreement><g:ConfirmationThatFinancialStatementGivesTrueAndFairViewOfAssetsLiabilitiesEquityFinancialPositionAndResults contextRef="c1" xml:lang="da">Vi anser den valgte regnskabspraksis for hensigtsmæssig, og efter vores opfattelse giver årsregnskabet et retvisende billede af selskabets aktiver, passiver og finansielle stilling pr. 31. december 2021 samt af resultatet af selskabets aktiviteter for regnskabsåret 1. januar - 31. december 2021.
</g:ConfirmationThatFinancialStatementGivesTrueAndFairViewOfAssetsLiabilitiesEquityFinancialPositionAndResults><g:ConfirmationThatFinancialStatementGivesTrueAndFairViewOfAssetsLiabilitiesEquityFinancialPositionAndResults contextRef="c1" xml:lang="en">We consider the accounting policies appropriate and, in our opinion, the financial statements provide a fair presentation of the company’s assets, equity and liabilities, and financial position at 31 December 2021 and of the company’s results of activities  in the financial year 1 January – 31 December 2021.
</g:ConfirmationThatFinancialStatementGivesTrueAndFairViewOfAssetsLiabilitiesEquityFinancialPositionAndResults><g:ConfirmationThatFinancialStatementsAreExemptedFromAuditing contextRef="c1" xml:lang="da">Direktionen anser betingelserne for at undlade revision af årsregnskabet for 2021 for opfyldt.
</g:ConfirmationThatFinancialStatementsAreExemptedFromAuditing><g:ConfirmationThatFinancialStatementsAreExemptedFromAuditing contextRef="c1" xml:lang="en">The executive board consider the conditions for audit exemption of the 2021 financial statements to be met.
</g:ConfirmationThatFinancialStatementsAreExemptedFromAuditing><g:ManagementsStatementAboutManagementsReview contextRef="c1" xml:lang="da">Ledelsesberetningen indeholder efter vores opfattelse en retvisende redegørelse for de forhold, som beretningen omhandler.
</g:ManagementsStatementAboutManagementsReview><g:ManagementsStatementAboutManagementsReview contextRef="c1" xml:lang="en">We are of the opinion that the management commentary presents a fair account of the issues dealt with.
</g:ManagementsStatementAboutManagementsReview><g:RecommendationForApprovalOfAnnualReportByGeneralMeeting contextRef="c1" xml:lang="da">Årsrapporten indstilles til generalforsamlingens godkendelse.
</g:RecommendationForApprovalOfAnnualReportByGeneralMeeting><g:RecommendationForApprovalOfAnnualReportByGeneralMeeting contextRef="c1" xml:lang="en">We recommend that the annual report be approved at the Annual General Meeting.
</g:RecommendationForApprovalOfAnnualReportByGeneralMeeting><d:NameAndSurnameOfMemberOfExecutiveBoard contextRef="c29">Tongzhou Wang</d:NameAndSurnameOfMemberOfExecutiveBoard><d:NameAndSurnameOfMemberOfExecutiveBoard contextRef="c28">Yongming Wang</d:NameAndSurnameOfMemberOfExecutiveBoard><f:DescriptionOfOtherEngagement contextRef="c1" xml:lang="da">Vi har opstillet årsregnskabet for Greatop Science &amp; Technology Development (Denmark) ApS for regnskabsåret 1. januar - 31. december 2021 på grundlag af selskabets bogføring og øvrige oplysninger, som De har tilvejebragt.

Årsregnskabet omfatter anvendt regnskabspraksis, resultatopgørelse, balance, egenkapitalopgørelse og noter.

Vi har udført opgaven i overensstemmelse med ISRS 4410, Opgaver om opstilling af finansielle oplysninger.

Vi har anvendt vores faglige ekspertise til at assistere Dem med at udarbejde og præsentere årsregnskabet i overensstemmelse med årsregnskabsloven. Vi har overholdt relevante bestemmelser i revisorloven og International Ethics Standards Board for Accountants’ internationale retningslinjer for revisorers etiske adfærd (IESBA Code), herunder principper om integritet, objektivitet, professionel kompetence og fornøden omhu.

Årsregnskabet samt nøjagtigheden og fuldstændigheden af de oplysninger, der er anvendt til opstillingen af årsregnskabet, er Deres ansvar.

Da en opgave om opstilling af finansielle oplysninger ikke er en erklæringsopgave med sikkerhed, er vi ikke forpligtet til at verificere nøjagtigheden eller fuldstændigheden af de oplysninger, De har givet os til brug for at opstille årsregnskabet. Vi udtrykker derfor ingen revisions- eller reviewkonklusion om, hvorvidt årsregnskabet er udarbejdet i overensstemmelse med årsregnskabsloven.
</f:DescriptionOfOtherEngagement><f:DescriptionOfOtherEngagement contextRef="c1" xml:lang="en">We have compiled the financial statements of Greatop Science &amp; Technology Development (Denmark) ApS for the financial year 1 January - 31 December 2021 based on the company's bookkeeping and on information you have provided.

These financial statements comprise a summary of significant accounting policies, income statement, balance sheet, statement of changes in equity and notes.

We performed this compilation engagement in accordance with International Standard on Related Services 4410 (Revised), Compilation Engagements.

We have applied our expertise in accounting and financial reporting to assist Management in the preparation and presentation of these financial statements in accordance with the Danish Financial Statements Act. We have complied with relevant requirements under the Danish Act on Approved Auditors and Audit Firms and International Ethics Standards Board for Accountants’ International Code of Ethics for Professional Accountants (IESBA Code) including principles of integrity, objectivity, professional competence and due care.

These financial statements and the accuracy and completeness of the information used to compile them are your responsibility.

Since a compilation engagement is not an assurance engagement, we are not required to verify the accuracy or completeness of the information you provided to us to compile these financial statements. Accordingly, we do not express an audit opinion or a review conclusion on whether these financial statements are prepared in accordance with the Danish Financial Statements Act.
</f:DescriptionOfOtherEngagement><h:DescriptionOfPrimaryActivitiesOfEntity contextRef="c1" xml:lang="da">Selskabets væsentligste aktiviteter
Selskabets primære aktivitet er forksning og eksperimentel udvikling indenfor bioteknologi. 
</h:DescriptionOfPrimaryActivitiesOfEntity><h:DescriptionOfPrimaryActivitiesOfEntity contextRef="c1" xml:lang="en">The principal activities of the company
The company's primary activity is research and experimental development on biotechnology.
</h:DescriptionOfPrimaryActivitiesOfEntity><h:DescriptionOfDevelopmentInActivitiesAndFinancialAffairs contextRef="c1" xml:lang="da">Udvikling i aktiviteter og økonomiske forhold
Selskabets underskud  har  medført  en  anstrengt  likviditet. Selskabet er således afhængig af  finansiering fra selskabets ejer for at kunne fortsætte driften.  Selskabets  ejer  har  tilkendegivet,  at  han  fortsat  vil  sikre  selskabet  tilstrækkelig  likviditet  til, at selskabet kan betragtes som i fortsat drift, og årsrapporten er således aflagt under disse forudsætninger.
</h:DescriptionOfDevelopmentInActivitiesAndFinancialAffairs><h:DescriptionOfDevelopmentInActivitiesAndFinancialAffairs contextRef="c1" xml:lang="en">Development in activities and financial matters
IThe  company's deficit  has  resulted  in  a  strained  liqiudity.  The company  is  dependent  on  funding  from  the shareholder of the company to continue operations.   The shareholder of the company have indicated that he will continue to ensure the company sufficient liquidity for the  company  to  be  considered  in  the  operation  and  the  annual  report  has  therefore  been  prepared  under  those conditions.
</h:DescriptionOfDevelopmentInActivitiesAndFinancialAffairs><h:DescriptionOfSignificantEventsOccurringAfterEndOfReportingPeriod contextRef="c1" xml:lang="da">Begivenheder efter regnskabsårets udløb
Efter regnskabsårets afslutning er der ikke ind-truffet begivenheder, som vil kunne forrykke selskabets finansielle stilling væsentligt. 
</h:DescriptionOfSignificantEventsOccurringAfterEndOfReportingPeriod><h:DescriptionOfSignificantEventsOccurringAfterEndOfReportingPeriod contextRef="c1" xml:lang="en">Events occurring after the end of the financial year
No events have occured subsequent to the balance sheet date, which would have material impact on the financial position of the company. 
</h:DescriptionOfSignificantEventsOccurringAfterEndOfReportingPeriod><e:InformationOnReportingClassOfEntity contextRef="c1" xml:lang="da">Årsrapporten for Greatop Science &amp; Technology Development (Denmark) ApS er aflagt i overensstemmelse med årsregnskabslovens bestemmelser for en klasse B-virksomhed. Herudover har virksomheden valgt at følge enkelte regler for klasse C-virksomheder.

Årsrapporten er aflagt efter samme regnskabspraksis som sidste år og aflægges i danske kroner.
</e:InformationOnReportingClassOfEntity><e:InformationOnReportingClassOfEntity contextRef="c1" xml:lang="en">The annual report for Greatop Science &amp; Technology Development (Denmark) ApS has been presented in accordance with the Danish Financial Statements Act regulations concerning reporting class B enterprises. Furthermore, the company has decided to comply with certain rules applying to reporting class C enterprises.

The accounting policies are unchanged from last year, and the annual report is presented in DKK.
</e:InformationOnReportingClassOfEntity><e:DescriptionOfGeneralMattersRelatedToRecognitionMeasurementAndChangesInAccountingPolicies contextRef="c1" xml:lang="da">Generelt om indregning og måling
I resultatopgørelsen indregnes indtægter i takt med, at de indtjenes. Herunder indregnes værdi-reguleringer af finansielle aktiver og forpligtelser. I resultatopgørelsen indregnes ligeledes alle omk-ostninger, herunder  afskrivninger, nedskrivninger og hensatte forpligtelser samt tilbageførsler som følge af  ændrede regnskabsmæssige skøn af beløb, der tidligere har været indregnet i resultatopgørel-sen.

Aktiver indregnes i balancen, når det er sandsynligt, at fremtidige økonomiske fordele vil tilflyde selskabet, og aktivets værdi kan måles pålideligt.

Forpligtelser indregnes i balancen, når det er sandsynligt, at fremtidige økonomiske fordele vil fragå selskabet, og forpligtelsens værdi kan måles pålideligt.

Ved første indregning måles aktiver og forpligtelser til kostpris. Efterfølgende måles aktiver og forpligtelser som beskrevet nedenfor for hver enkelt regnskabspost.

Ved indregning og måling tages hensyn til forudsigelige tab og risici, der fremkommer inden årsrapporten aflægges, og som vedrører forhold, der eksisterede på balancedagen.
</e:DescriptionOfGeneralMattersRelatedToRecognitionMeasurementAndChangesInAccountingPolicies><e:DescriptionOfGeneralMattersRelatedToRecognitionMeasurementAndChangesInAccountingPolicies contextRef="c1" xml:lang="en">Recognition and measurement in general
Income is  recognised in the profit and loss account concurrently with its  realisation, including the recognition of value adjustments of financial assets and liabilities. Likewise, all costs, these including depreciation, amortisation, writedown, provisions, and reversals which are due to changes in estimated amounts previously recognised in the profit and loss account are recognised in the profit and loss account.

Assets are recognised in the balance sheet when the company is liable to achieve future, financial benefits and the value of the asset can be measured reliably.

Liabilities are recognised in the statement of financial position when it is seems probable that future economic benefits will flow out of the company and the value of the liability can be reliably measured.

Assets and liabilities are measured at cost at the initial recognition. Hereafter, assets and liabilities are measured as described below for each individual accounting item.

Upon recognition and measurement, allowances are made for such predictable losses and risks which may arise prior to the presentation of the annual report and concern matters that exist on the reporting date.
</e:DescriptionOfGeneralMattersRelatedToRecognitionMeasurementAndChangesInAccountingPolicies><e:DescriptionOfMethodsOfForeignCurrencies contextRef="c1" xml:lang="da">Omregning af fremmed valuta
Transaktioner i fremmed valuta omregnes til transaktionsdagens kurs. Valutakursdifferencer, der opstår mellem transaktionsdagens kurs og kursen på betalingsdagen, indregnes i resultatopgørelsen som en finansiel post. 

Tilgodehavender, gæld og andre monetære poster i fremmed valuta, omregnes til balancedagens valutakurs. Forskellen mellem balancedagens kurs og kursen på tidspunktet for tilgodehavendets eller gældsforpligtelsens opståen eller indregning i seneste årsregnskab indregnes i resultatopgørelsen under finansielle indtægter og omkostninger.
</e:DescriptionOfMethodsOfForeignCurrencies><e:DescriptionOfMethodsOfForeignCurrencies contextRef="c1" xml:lang="en">Foreign currency translation
Transactions in foreign currency are translated by using the exchange rate prevailing at the date of the transaction. Differences in the rate of exchange arising between the rate at the date of transaction and the rate at the date of payment are recognised in the profit and loss account as an item under net financials.

Receivables, payables, and other foreign currency monetary items are translated using the closing rate. The difference between the closing rate and the rate at the time of the occurrence or initial recognition in the latest financial statements of the receivable or payable is recognised in the income statement under financial income and expenses.
</e:DescriptionOfMethodsOfForeignCurrencies><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfRevenue contextRef="c1" xml:lang="da">Bruttofortjeneste
Bruttofortjeneste indeholder nettoomsætning og eksterne omkostninger.

Nettoomsætning omfatter værdien af årets leverede ydelser, inklusive udlæg for kunder med fradrag af merværdiafgift og prisnedslag, der er direkte forbundet med salget.

Nettoomsætning indregnes i resultatopgørelsen, når salget er gennemført. Dette anses generelt for at være tilfældet, når:
Tjenesteydelsen er leveret inden regnskabsårets udløb
Der foreligger en forpligtende salgsaftale
Salgsprisen er fastlagt
Indbetalingen er modtaget eller med rimelig sikkerhed kan forventes modtaget

Det sikres hermed, at indregningen først sker, når de samlede indtægter og omkostninger samt færdiggørelsesgraden på balancedagen kan opgøres pålideligt, og det er sandsynligt, at de økonomiske fordele, herunder betalinger, vil tilgå virksomheden.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfRevenue><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfRevenue contextRef="c1" xml:lang="en">Gross profit
Gross profit comprises the revenue and external costs.

Revenue comprises the value of services provided during the year, including outlay for customers less VAT and price concessions directly associated with the sale.

Revenue is recognised in the income statement on the completion of sales. This is generally considered to be the case when:
The service has been provided before the end of the financial year
A binding sales agreement exists
The sales price has been determined
Payment has been received, or is anticipated with a reasonable degree of certainty.

This ensures that recognition does not take place until the total income and costs and stage of completion at the reporting date can be reliably validated and it seems probable that the economic benefits, including payments, will flow to the enterprise.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfRevenue><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfCostOfSales contextRef="c1" xml:lang="da">Vareforbrug omfatter omkostninger til køb af råvarer og hjælpematerialer med fradrag af rabatter samt årets forskydning i varebeholdninger.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfCostOfSales><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfCostOfSales contextRef="c1" xml:lang="en">Cost of sales comprises costs concerning purchase of raw materials and consumables less discounts and changes in inventories.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfCostOfSales><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfExternalExpenses contextRef="c1" xml:lang="da">Andre eksterne omkostninger omfatter omkostninger til distribution, salg, reklame, administration og lokaler.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfExternalExpenses><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfExternalExpenses contextRef="c1" xml:lang="en">Other external costs comprise costs incurred for distribution, sales, advertising, administration, and premises.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfExternalExpenses><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfEmployeeBenefitExpense contextRef="c1" xml:lang="da">Personaleomkostninger
Personaleomkostninger omfatter løn og gager, inklusive feriepenge og pensioner samt andre omkostninger til social sikring mv. til selskabets medarbejdere. I personaleomkostninger er fratrukket modtagne godtgørelser fra offentlige myndigheder.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfEmployeeBenefitExpense><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfEmployeeBenefitExpense contextRef="c1" xml:lang="en">Staff costs
Staff costs include salaries and wages, including holiday allowances, pensions, and other social security costs, etc., for staff members. Staff costs are less government reimbursements.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfEmployeeBenefitExpense><e:DescriptionOfMethodsOfImpairmentLossesAndDepreciation contextRef="c1" xml:lang="da">Af- og nedskrivninger
Af- og nedskrivninger indeholder årets af- og nedskrivninger af immaterielle og materielle anlægsaktiver.
</e:DescriptionOfMethodsOfImpairmentLossesAndDepreciation><e:DescriptionOfMethodsOfImpairmentLossesAndDepreciation contextRef="c1" xml:lang="en">Depreciation, amortisation, and writedown for impairment
Depreciation, amortisation, and writedown for impairment comprise depreciation on, amortisation of, and writedown for impairment of intangible and tangible assets, respectively.
</e:DescriptionOfMethodsOfImpairmentLossesAndDepreciation><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfFinanceIncomeAndExpenses contextRef="c1" xml:lang="da">Finansielle indtægter og omkostninger
Finansielle indtægter og omkostninger indregnes i resultatopgørelsen med de beløb, der vedrører regnskabsåret. Finansielle poster omfatter renteindtægter og -omkostninger, finansielle omkostninger ved finansiel leasing, realiserede og urealiserede kursgevinster og kurstab vedrørende værdipapirer, gæld og transaktioner i fremmed valuta, amortisering af finansielle aktiver og forpligtelser samt tillæg og godtgørelser under acontoskatteordningen mv.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfFinanceIncomeAndExpenses><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfFinanceIncomeAndExpenses contextRef="c1" xml:lang="en">Financial income and expenses
Financial income and expenses are recognised in the income statement with the amounts concerning the financial year. Financial income and expenses comprise interest income and expenses, financial expenses from financial leasing, realised and unrealised capital gains and losses relating to securities, debt and transactions in foreign currency, amortisation of financial assets and liabilities as well as surcharges and reimbursements under the advance tax scheme, etc.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfFinanceIncomeAndExpenses><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfIncomeAndExpensesFromInvestmentsInGroupEnterprisesAndAssociates contextRef="c1" xml:lang="da">Indtægter af kapitalandel kapitalinteresse
I resultatopgørelsen indregnes den forholdsmæssige andel af kapitalinteressens resultat efter skat efter eliminering af forholdsmæssig andel af intern avance eller tab og fradrag af afskrivning på goodwill og tillæg af negativ goodwill.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfIncomeAndExpensesFromInvestmentsInGroupEnterprisesAndAssociates><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfIncomeAndExpensesFromInvestmentsInGroupEnterprisesAndAssociates contextRef="c1" xml:lang="en">Results from equity investment in equity interest
After full elimination of intercompany profit or loss less amortised of consolidated goodwill, the investment in the participating interest is recognised in the income statement as a proportional share of the participating interests’ post-tax profit or loss.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfIncomeAndExpensesFromInvestmentsInGroupEnterprisesAndAssociates><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxExpenses contextRef="c1" xml:lang="da">Skat af årets resultat
Årets skat, der består af årets aktuelle selskabsskat og ændring i udskudt skat, indregnes i resultatopgørelsen med den del, der kan henføres til årets resultat, og direkte i egenkapitalen med den del, der kan henføres til posteringer direkte i egenkapitalen. 

Modervirksomheden og de danske tilknyttede virksomheder er omfattet af de danske regler om tvungen sambeskatning af koncernens danske virksomheder.

Den aktuelle danske selskabsskat fordeles ved afregning af sambeskatningsbidrag mellem de sambeskattede virksomheder i forhold til disses skattepligtige indkomster. I tilknytning hertil modtager virksomheder med skattemæssigt underskud sambeskatningsbidrag fra virksomheder, der har kunnet anvende dette underskud (fuld fordeling).
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxExpenses><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxExpenses contextRef="c1" xml:lang="en">Tax on net profit or loss for the year
Tax for the year comprises the current income tax for the year and changes in deferred tax and is recognised in the income statement with the share attributable to the net profit or loss for the year and directly in equity with the share attributable to entries directly in equity. 

The company is subject to Danish rules on compulsory joint taxation of Danish group enterprises.

The current Danish income tax is allocated among the jointly taxed companies proportional to their respective taxable income (full allocation with reimbursement of tax losses).
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxExpenses><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfPropertyPlantAndEquipment contextRef="c1" xml:lang="da">Materielle anlægsaktiver
Materielle anlægsaktiver måles til kostpris med fradrag af akkumulerede afskrivninger og nedskrivninger. Der afskrives ikke på grunde.

Afskrivningsgrundlaget er kostpris med fradrag af eventuel forventet restværdi efter afsluttet brugstid. Afskrivningsperioden og restværdien fastsættes på anskaffelsestidspunktet og revurderes årligt. Overstiger restværdien aktivets regnskabsmæssige værdi, ophører afskrivningen.

Kostprisen omfatter anskaffelsesprisen samt omkostninger direkte tilknyttet anskaffelsen indtil det tidspunkt, hvor aktivet er klar til at blive taget i brug.

Der foretages lineære afskrivninger baseret på følgende vurdering af aktivernes forventede brugstider og restværdier:

Bygninger Brugstid 30 år Restværdi 20 %
Andre anlæg, driftsmateriel og inventar Brugstid 3-5 år Restværdi 0-20 %
Småaktiver med en forventet levetid under 1 år indregnes i anskaffelsesåret som omkostninger i resultatopgørelsen.

Fortjeneste eller tab ved afhændelse af materielle anlægsaktiver opgøres som forskellen mellem salgspris med fradrag af salgsomkostninger og den regnskabsmæssige værdi på salgstidspunktet. Fortjeneste eller tab indregnes i resultatopgørelsen under andre driftsindtægter eller andre driftsomkostninger.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfPropertyPlantAndEquipment><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfPropertyPlantAndEquipment contextRef="c1" xml:lang="en">Tangible fixed assets
Tangible fixed assets are measured at cost with  deduction  of  accrued  depreciation  and  write-down.  Land  is  not depreciated.

The depreciable amount is cost less any expected residual value after the end of the useful life of the asset. The amortisation period and the residual value are determined at the acquisition date and reassessed annually. If the residual value exceeds the carrying amount, the depreciation is discontinued.

The cost comprises acquisition cost and costs directly associated with the acquisition until the time when the asset is ready for use.

Depreciation is done on a straight-line basis according to an assessment of the expected useful life  and the residual value of the individual assets:

Buildings Useful life 30 years Residual value 20 %
Other fixtures and fittings, tools and equipment Useful life 3-5 years Residual value 0-20 %
Minor assets with an expected useful life of less than 1 year are recognised as costs in the income statement in the year of acquisition.

Profit or loss derived from the disposal of property, land, and equipment is measured as the difference between the sales price less selling costs and the carrying amount at the date of disposal. Profit or loss is recognised in the income statement as other operating income or other operating expenses.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfPropertyPlantAndEquipment><e:DescriptionOfMethodsOfAmortisationOfNoncurrentAssets contextRef="c1" xml:lang="da">Nedskrivning på anlægsaktiver
Den regnskabsmæssige værdi af såvel immaterielle som materielle anlægsaktiver samt kapitalandel i kapitalinteresse vurderes årligt for indikationer på værdiforringelse ud over det, som udtrykkes ved afskrivning.

Foreligger der indikationer på værdiforringelse, foretages nedskrivningstest af hvert enkelt aktiv henholdsvis gruppe af aktiver. Der foretages nedskrivning til genindvindingsværdien, såfremt denne er lavere end den regnskabsmæssige værdi.

Genindvindingsværdien er den højeste værdi af kapitalværdi og salgsværdi fratrukket forventede omkostninger ved et salg. Kapitalværdien opgøres som nutidsværdien af de forventede nettopengestrømme fra anvendelsen af aktivet eller aktivgruppen og forventede nettopenge-strømme ved salg af aktivet eller aktivgruppen efter endt brugstid.

Tidligere indregnede nedskrivninger tilbageføres, når betingelsen for nedskrivningen ikke længere består. Nedskrivninger på goodwill tilbageføres ikke.
</e:DescriptionOfMethodsOfAmortisationOfNoncurrentAssets><e:DescriptionOfMethodsOfAmortisationOfNoncurrentAssets contextRef="c1" xml:lang="en">Impairment loss relating to non-current assets
The carrying amount of both intangible and tangible fixed assets as well as equity investment in participating interest are subject to annual impairment tests in order to disclose any indications of impairment beyond those expressed by amortisation and depreciation respectively.

If indications of impairment are disclosed, impairment tests are carried out for each individual asset or group of assets, respectively. Writedown for impairment is done to the recoverable amount if this value is lower than the carrying amount.

The recoverable amount is the higher value of value in use and selling price less expected selling cost. The value in use is calculated as the present value of the expected net cash flows from the use of the asset or the asset group and expected net cash flows from the sale of the asset or the asset group after the end of their useful life.

Previously recognised impairment losses are reversed when conditions for impairment no longer exist. Impairment relating to goodwill is not reversed.
</e:DescriptionOfMethodsOfAmortisationOfNoncurrentAssets><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisForInvestmentsInSubsidiariesAndAssociates contextRef="c1" xml:lang="da">Kapitalandel i kapitalinteresse 
Kapitalandel i kapitalintesse indregnes og måles efter den indre værdis metode. Indre værdis metode anvendes som en målemetode.

I balancen indregnes kapitalandel i kapitalinteresse til den forholdsmæssige andel af virksomhedens regnskabsmæssige indre værdi. Denne opgøres efter ejervirksomhedens regnskabspraksis med fradrag eller tillæg af urealiserede koncerninterne avancer og tab samt med tillæg eller fradrag af resterende værdi af positiv eller negativ goodwill opgjort efter overtagelsesmetoden. Negativ goodwill indregnes i resultatopgørelsen ved købet af kapitalandelen. Vedrører den negative goodwill overtagne eventualforpligtelser, indtægtsføres negativ goodwill først, når eventualforpligtelserne er afviklet eller bortfaldet.

Kapitalandel i kapitalinteresse med regnskabsmæssig negativ indre værdi måles til 0 kr., og et eventuelt tilgodehavende hos disse virksomheder nedskrives, i det omfang tilgodehavendet er uerholdeligt. I det omfang ejervirksomheden har en retlig eller faktisk forpligtelse til at dække en underbalance, der overstiger tilgodehavendet, indregnes det resterende beløb under hensatte forpligtelser.

Nettoopskrivning af kapitalandel i kapitalinteresse overføres under egenkapitalen til reserve for nettoopskrivning efter den indre værdis metode i det omfang, den regnskabsmæssige værdi overstiger kostprisen. Reserven reguleres med andre egenkapitalbevægelser i kapitalinteresse.

Nyerhvervede eller nystiftede virksomheder indregnes i årsregnskabet fra anskaffelsestidspunktet. Solgte eller afviklede virksomheder indregnes frem til afståelsestidspunktet.

Ved køb af virksomheder anvendes overtagelsesmetoden, sammenlægningsmetoden eller bogført værdi metoden, jf. beskrivelse ovenfor under Virksomhedssammenslutninger.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisForInvestmentsInSubsidiariesAndAssociates><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisForInvestmentsInSubsidiariesAndAssociates contextRef="c1" xml:lang="en">Equity in equity interest
Equity in equity interest are recognised and measured by applying the equity method. The equity method is used as a measurement method.

Equity in equity interest are recognised in the statement of financial position at the proportionate share of the enterprise's equity value. This value is calculated in accordance with the accounting policies of the owner compagny with deductions or additions of unrealised intercompany gains and losses as well as with additions or deductions of the remaining value of positive or negative goodwill calculated in accordance with the acquisition method. Negative goodwill is recognised in the income statement at the time of acquisition of the equity investment. If the negative goodwill relates to contingent liabilities acquired, negative goodwill is not recognised until the contingent liabilities have been settled or lapsed.

Equity  in equity interest with a negative equity value  measured at DKK 0, and any accounts receivable from these enterprises are written down to the extent that the account receivable is uncollectible. To the extent that the parent has a legal or constructive obligation to cover an negative balance that exceeds the account receivable, the remaining amount is recognised under provisions

To the extent the equity exceeds the cost, the net revaluation of participating interest  transferred to the reserve under equity for net revaluation according to the equity method. The reserve is adjusted by other equity movements in participating interest.

Newly acquired or newly established companies are recognised in the financial statement as of the time of acquisition. Sold or liquidated companies are recognised until the date of disposal.

On the acquisition of enterprises, the acquisition method, the uniting-of-interests method or the book value method is applied, cf. the above description under Business combinations.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisForInvestmentsInSubsidiariesAndAssociates><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfReceivables contextRef="c1" xml:lang="da">Tilgodehavender
Tilgodehavender måles til amortiseret kostpris, hvilket sædvanligvis svarer til nominel værdi. Der nedskrives til nettorealisationsværdien med henblik på at imødegå forventede tab.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfReceivables><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfReceivables contextRef="c1" xml:lang="en">Receivables
Receivables are measured at amortised cost which usually corresponds to face value. In order to meet expected losses, they are written down for impairment to the net realisable value.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfReceivables><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfDeferredIncomeAssets contextRef="c1" xml:lang="da">Periodeafgrænsningsposter
Periodeafgrænsningsposter, som er indregnet under aktiver, omfatter afholdte omkostninger vedrørende efterfølgende regnskabsår.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfDeferredIncomeAssets><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfDeferredIncomeAssets contextRef="c1" xml:lang="en">Prepayments and accrued income
Prepayments and accrued income recognised under assets comprise incurred costs concerning the following financial year.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfDeferredIncomeAssets><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfCashAndCashEquivalents contextRef="c1" xml:lang="da">Likvide beholdninger
Likvide beholdninger omfatter indeståender i pengeinstitutter og kontantbeholdninger.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfCashAndCashEquivalents><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfCashAndCashEquivalents contextRef="c1" xml:lang="en">Cash on hand and demand deposits
Cash on hand and demand deposits comprise cash at bank and on hand.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfCashAndCashEquivalents><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxPayablesAndDeferredTax contextRef="c1" xml:lang="da">Selskabsskat og udskudt skat
Aktuelle skatteforpligtelser og tilgodehavende aktuel skat indregnes i balancen som beregnet skat af årets skattepligtige indkomst, reguleret for skat af tidligere års skattepligtige indkomster og for betalte acontoskatter.

Selskabet er sambeskattet med koncernforbundne danske selskaber. Den aktuelle selskabsskat fordeles mellem de sambeskattede selskaber i forhold til disses skattepligtige indkomster og med fuld fordeling med refusion vedrørende skattemæssige underskud. De sambeskattede selskaber indgår i acontoskatteordningen.

Efter sambeskatningsreglerne hæfter Greatop Science &amp; Technology Development (Denmark) ApS solidarisk og ubegrænset over for skattemyndighederne for selskabsskatter og kildeskatter på renter, royalties og udbytter opstået inden for sambeskatningskredsen.

Der foretages regulering af udskudt skat vedrørende foretagne elimineringer af urealiserede koncerninterne avancer og -tab.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxPayablesAndDeferredTax><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxPayablesAndDeferredTax contextRef="c1" xml:lang="en">Income tax and deferred tax
Current tax liabilities and current tax receivable are recognised in the statement of financial position as calculated tax on the taxable income for the year, adjusted for tax of previous years' taxable income and for tax paid on account.

The company is jointly taxed with consolidated Danish companies. The current corporate income tax is distributed between the jointly taxed companies in proportion to their taxable income and with full distribution with reimbursement as to tax losses. The jointly taxed companies are comprised by the Danish tax prepayment scheme.

According to the rules of joint taxation, Greatop Science &amp; Technology Development (Denmark) ApS is unlimitedly, jointly, and severally liable to pay the Danish tax authorities the total income tax, including withholding tax on interest, royalties, and dividends, arising from the jointly taxed group of companies.

Adjustments take place in relation to deferred tax concerning elimination of unrealised intercompany gains and losses.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxPayablesAndDeferredTax><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfLiabilitiesOtherThanProvisions contextRef="c1" xml:lang="da">Gældsforpligtelser
Øvrige gældsforpligtelser, som omfatter gæld til leverandører, tilknyttede virksomheder samt anden gæld, måles til amortiseret kostpris, hvilket sædvanligvis svarer til nominel værdi.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfLiabilitiesOtherThanProvisions><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfLiabilitiesOtherThanProvisions contextRef="c1" xml:lang="en">Liabilities other than provisions
Other liabilities concerning payables to suppliers, group enterprises, and other payables are measured at amortised cost which usually corresponds to the nominal value.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfLiabilitiesOtherThanProvisions><e:DisclosureOfUncertaintiesRelatingToGoingConcern contextRef="c1" xml:lang="da">1.
Fortsat drift
Going concern
Selskabets underskud har medført en anstrengt likviditet. Selskabet er således afhængig af finansiering fra selskabets ejer for at kunne fortsætte driften. Selskabets erjer har tilkendegivet, at han fortsat vil sikre selskabet tilstrækkelig likviditet til, at selskabet kan betragtes som i fortsat drift, og årsrapporten er således aflagt under disse forudsætninger.
The company's deficit has resulted in a strained liqiudity. The company is dependent on funding from the shareholder of the company to continue operations. The shareholder of the company have indicated that he will continue to ensure the company sufficient liquidity for the company to be considered in the operation and the annual report has therefore been prepared under those conditions.


</e:DisclosureOfUncertaintiesRelatingToGoingConcern><e:DisclosureOfContingentLiabilities contextRef="c1" xml:lang="da">5. Eventualposter
Contingencies
Sambeskatning
Joint taxation
Selskabet indgår i den nationale sambeskatning med Greatop Science and Technology Development (Europe) ApS, CVR-nr. 42 49 67 74, som administrationsselskab og hæfter ubegrænset og solidarisk med de øvrige sambeskattede selskaber for den samlede selskabsskat.
With Greatop Science and Technology Development (Europe) ApS, company reg. no 42 49 67 74 as administration company, the company is subject to the Danish scheme of joint taxation and unlimitedly, jointly, and severally liable, along with the other jointly taxed companies, for the total corporation tax.

Selskabet hæfter ubegrænset og solidarisk med de øvrige sambeskattede selskaber for eventuelle forpligtelser til at indeholde kildeskat på renter, royalties og udbytter.
The company is unlimitedly, jointly, and severally liable, along with the other jointly taxed companies, for any obligations to withhold tax on interest, royalties, and dividends.

Eventuelle senere korrektioner af selskabsskatter eller kildeskatter mv. vil kunne medføre, at selskabets hæftelse udgør et andet beløb.
Any subsequent adjustments of corporate taxes or withholding tax, etc., may result in changes in the company's liabilities.

</e:DisclosureOfContingentLiabilities><!--Aktuelle periode enkelt selskab--><context id="c1"><entity><identifier scheme="http://www.dcca.dk/cvr">35861637</identifier></entity><period><startDate>2021-01-01</startDate><endDate>2021-12-31</endDate></period></context><!--Forrige periode enkelt selskab--><context id="c2"><entity><identifier scheme="http://www.dcca.dk/cvr">35861637</identifier></entity><period><startDate>2020-01-01</startDate><endDate>2020-12-31</endDate></period></context><!--Slutdato forrige periode enkelt selskab--><context id="c3"><entity><identifier scheme="http://www.dcca.dk/cvr">35861637</identifier></entity><period><instant>2020-12-31</instant></period></context><!--Slutdato aktuelle periode enkelt selskab--><context id="c4"><entity><identifier scheme="http://www.dcca.dk/cvr">35861637</identifier></entity><period><instant>2021-12-31</instant></period></context><!--CEO2--><context id="c28"><entity><identifier scheme="http://www.dcca.dk/cvr">35861637</identifier></entity><period><startDate>2021-01-01</startDate><endDate>2021-12-31</endDate></period><scenario><xbrldi:typedMember dimension="d:IdentificationOfMemberOfExecutiveBoardDimension"><d:memberOfBoardIdentifier>2</d:memberOfBoardIdentifier></xbrldi:typedMember></scenario></context><!--CEO1--><context id="c29"><entity><identifier scheme="http://www.dcca.dk/cvr">35861637</identifier></entity><period><startDate>2021-01-01</startDate><endDate>2021-12-31</endDate></period><scenario><xbrldi:typedMember dimension="d:IdentificationOfMemberOfExecutiveBoardDimension"><d:memberOfBoardIdentifier>1</d:memberOfBoardIdentifier></xbrldi:typedMember></scenario></context><!--REVISOR1--><context id="c37"><entity><identifier scheme="http://www.dcca.dk/cvr">35861637</identifier></entity><period><startDate>2021-01-01</startDate><endDate>2021-12-31</endDate></period><scenario><xbrldi:typedMember dimension="d:IdentificationOfAuditorDimension"><d:auditorIdentifier>1</d:auditorIdentifier></xbrldi:typedMember></scenario></context><!--REVISOR2--><context id="c38"><entity><identifier scheme="http://www.dcca.dk/cvr">35861637</identifier></entity><period><startDate>2021-01-01</startDate><endDate>2021-12-31</endDate></period><scenario><xbrldi:typedMember dimension="d:IdentificationOfAuditorDimension"><d:auditorIdentifier>2</d:auditorIdentifier></xbrldi:typedMember></scenario></context><!--Overfoert resultat aktuel i aaret--><context id="c63"><entity><identifier scheme="http://www.dcca.dk/cvr">35861637</identifier></entity><period><startDate>2021-01-01</startDate><endDate>2021-12-31</endDate></period><scenario><xbrldi:explicitMember dimension="e:ResultDistributionDimension">e:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--Overfoert resultat forrige i aaret--><context id="c64"><entity><identifier scheme="http://www.dcca.dk/cvr">35861637</identifier></entity><period><startDate>2020-01-01</startDate><endDate>2020-12-31</endDate></period><scenario><xbrldi:explicitMember dimension="e:ResultDistributionDimension">e:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--Virksomhedskapital aktuel primo--><context id="c119"><entity><identifier scheme="http://www.dcca.dk/cvr">35861637</identifier></entity><period><instant>2021-01-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ContributedCapitalMember</xbrldi:explicitMember></scenario></context><!--Virksomhedskapital aktuel i aaret--><context id="c120"><entity><identifier scheme="http://www.dcca.dk/cvr">35861637</identifier></entity><period><startDate>2021-01-01</startDate><endDate>2021-12-31</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ContributedCapitalMember</xbrldi:explicitMember></scenario></context><!--Virksomhedskapital aktuel ultimo--><context id="c121"><entity><identifier scheme="http://www.dcca.dk/cvr">35861637</identifier></entity><period><instant>2021-12-31</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ContributedCapitalMember</xbrldi:explicitMember></scenario></context><!--Overfort res aktuel primo--><context id="c137"><entity><identifier scheme="http://www.dcca.dk/cvr">35861637</identifier></entity><period><instant>2021-01-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--Overfort res aktuel i aaret--><context id="c138"><entity><identifier scheme="http://www.dcca.dk/cvr">35861637</identifier></entity><period><startDate>2021-01-01</startDate><endDate>2021-12-31</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--Overfort res aktuel ultimo--><context id="c139"><entity><identifier scheme="http://www.dcca.dk/cvr">35861637</identifier></entity><period><instant>2021-12-31</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--Virksomhedskapital forrige EKprimo--><context id="c478"><entity><identifier scheme="http://www.dcca.dk/cvr">35861637</identifier></entity><period><instant>2020-01-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ContributedCapitalMember</xbrldi:explicitMember></scenario></context><!--Virksomhedskapital forrige EKi aaret--><context id="c479"><entity><identifier scheme="http://www.dcca.dk/cvr">35861637</identifier></entity><period><startDate>2020-01-01</startDate><endDate>2020-12-31</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ContributedCapitalMember</xbrldi:explicitMember></scenario></context><!--Virksomhedskapital forrige EKultimo--><context id="c480"><entity><identifier scheme="http://www.dcca.dk/cvr">35861637</identifier></entity><period><instant>2020-12-31</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ContributedCapitalMember</xbrldi:explicitMember></scenario></context><!--Overfort res forrige EKprimo--><context id="c498"><entity><identifier scheme="http://www.dcca.dk/cvr">35861637</identifier></entity><period><instant>2020-01-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--Overfort res forrige EKi aaret--><context id="c499"><entity><identifier scheme="http://www.dcca.dk/cvr">35861637</identifier></entity><period><startDate>2020-01-01</startDate><endDate>2020-12-31</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--Overfort res forrige EKultimo--><context id="c500"><entity><identifier scheme="http://www.dcca.dk/cvr">35861637</identifier></entity><period><instant>2020-12-31</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--DKK enere--><unit id="u5"><measure>iso4217:DKK</measure></unit><!--Antal--><unit id="u7"><measure>xbrli:pure</measure></unit></xbrl>
